All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 74 of 206 pages ‹ First < 72 73 74 75 76 > Last ›
HSL11432
Goldacre B.
Journalists: anything to declare?
BMJ 2007 Sep 8;335:(7618):480
http://www.bmj.com/cgi/content/extract/335/7618/480
HSL11553
White C.
Cancer expert attacks drug company's funding of research paper.
BMJ 2007 Sep 8;335:(7618):469
http://www.bmj.com/cgi/content/extract/335/7618/469-a
HSL11410
Generics campaign
Pharmacy Daily (Australia) - registration required 2007 Sep 7
http://www.pharmacydaily.com.au
HSL11412
Murphy T.
Lilly, Doctor Reach Agreement Over Leak
Associated Press 2007 Sep 7
http://biz.yahoo.com/ap/070907/ny_times_zyprexa.html?.v=3
HSL11413
Tesoriero HW.
Vioxx Ruling Eases Threat to Merck
The Wall Street Journal 2007 Sep 7A3
http://online.wsj.com/article/SB118912340920719996.html
HSL11425
Harris G.
Senators Seek Public Listing of Payments to Doctors
New York Times 2007 Sep 7
http://www.nytimes.com/2007/09/07/washington/07doctors.html?_r=1&oref=slogin
HSL11437
Read J.
Schizophrenia, drug companies and the internet.
Soc Sci Med 2007 Sep 7;Epub ahead of print
http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=inwardhub&_urlversion=4&_method=citationSearch&_piikey=S0277953607004315&_referrer=www.ncbi.nlm.nih.gov%2Fsites%2Fentrez&_version=1&md5=c8e5d0fc31a5f2d513592095763c656a
HSL11467
Statement of Eli Lilly and Company on Dr. David Egilman Settlement
PharmaLive 2007 Sep 7
http://pharmalive.com/news/index.cfm?articleID=473251&categoryid=43
HSL11489
Towards Centralised and Transparent Marketing Authorisations for all Medicines
The Medicines in Europe Forum/The International Society of Drug Bulletins 2007 Sep 7
HSL11607
Miller G.
Living in societies.The art of virtual persuasion
Science. 2007 Sep 7;317:(5843):1343
http://www.sciencemag.org/cgi/content/full/317/5843/1343
HSL15795
Noyes J.
Firm looks to build buzz around prescription drugs
Boston Business Journal 2007 Sep 7
http://boston.bizjournals.com/boston/stories/2007/09/10/story16.html
HSL11403
Smith SW.
Sidelining Safety — The FDA's Inadequate Response to the IOM
NEJM 2007 Sep 6;357:(10):960-963
http://content.nejm.org/cgi/content/full/357/10/960
HSL11424
Koroneos G.
Data Clamp Down
Pharmaceutical Executive 2007 Sep 6
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=454637
HSL11428
Hébert PC, Stanbrook M.
Indication creep: physician beware
CMAJ 2007 Sep 6;epub ahead of print
http://www.cmaj.ca/cgi/rapidpdf/cmaj.071223
HSL11496
Sens. Grassley, Kohl Say Public Should Know When Pharmaceutical Makers Give Money to Doctors
PharmaLive 2007 Sep 6
http://pharmalive.com/news/index.cfm?articleID=473114&categoryid=43
HSL11400
Indian firms rapped over 'unapproved, overpriced' drugs
Pharma Times 2007 Sep 5
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11668
HSL11404
Waters R.
J&J, Pfizer Profit on `Juvenile Bipolar Juggernaut'
Bloomberg News 2007 Sep 5
http://www.bloomberg.com/apps/news?pid=20601109&sid=aBYgkHznuux0&refer=home
HSL11409
Hirschler B.
Bogus drug peddlers thrive in cyberspace
Reuters 2007 Sep 5
http://today.reuters.com/news/articlenews.aspx?type=healthNews&storyID=2007-09-05T100846Z_01_L0368306_RTRUKOC_0_US-MEDICINES-COUNTERFEIT.xml&pageNumber=0&imageid=&cap=&sz=13&WTModLoc=NewsArt-C1-ArticlePage2
HSL11411
Norsigian J, Stephenson H.
HPV Vaccine Flags Need for More Pap Tests
Women's eNews 2007 Sep 5
http://www.womensenews.org/article.cfm?aid=3303
HSL11426
Windish DM, Huot SJ, Green ML.
Medicine Residents' Understanding of the Biostatistics and Results in the Medical Literature
JAMA. 2007 Sep 5;298:(9):1010-1022
http://jama.ama-assn.org/cgi/content/abstract/298/9/1010
HSL11569
Houx K.
Medical groups, state senator seek drug company disclosures
KC Community News (Kansas City) 2007 Sep 5
http://www.kccommunitynews.com/articles/2007/09/05/wednesday_sun/news/c-ws-news-medical.groups.txt
HSL11704
Boonyasai RT, Windish DM, Chakraborti C, Feldman LS, Rubin HR, Bass EB.
Effectiveness of teaching quality improvement to clinicians: a systematic review.
JAMA 2007 Sep 5;298:(9):1023-37
http://jama.ama-assn.org/cgi/content/full/298/9/1023
HSL11392
Formula code slammed
Pharmacy Daily (Australia) - registration required 2007 Sep 4
http://www.pharmacydaily.com.au
HSL11394
Carey B.
Bipolar Illness Soars as a Diagnosis for the Young
New York Times 2007 Sep 4
http://www.nytimes.com/2007/09/04/health/04psych.html?n=Top/Reference/Times%20Topics/People/C/Carey,%20Benedict&_r=1&adxnnl=1&oref=slogin&adxnnlx=1188990833-5Bs00BkUwrwt6zh6jAKFTQ
HSL11395
Gellene D.
Bipolar disorder in youths may be over-diagnosed
Los Angeles Times 2007 Sep 4
http://www.latimes.com/news/nationworld/nation/la-sci-bipolar4sep04,1,145237.story?coll=la-headlines-nation
HSL11398
Open access to health research publications: CIHR unveils new policy
Canadian Institutes of Health Research 2007 Sep 4
http://www.cihr.ca/e/34851.html
HSL11399
Healy M.
The business of prescription drugs
Los Angeles Times 2007 Sep 4
http://dailycamera.com/news/2007/sep/04/the-business-of-prescription-drugs-efforts-to/
HSL11402
Silverman E.
Novartis Flu Contest: The Patient As Marketer
Pharmalot 2007 Sep 4
http://www.pharmalot.com/2007/09/novartis-flu-contest-the-patient-as-marketer/
HSL11421
Pfizer's 'Viva Viagra' TV ads come under fire
PMLive.com 2007 Sep 4
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=5856
HSL11503
Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, Meredith LS, Rubenstein LV.
The effect of adherence to practice guidelines on depression outcomes.
Ann Intern Med 2007 Sep 4;147:(5):320-9
http://www.annals.org/cgi/content/abstract/147/5/320
HSL11300
O'Reilly KB.
Drug rep creates stir with details on tricks of his trade
American Medical News 2007 Sep 3
http://www.ama-assn.org/amednews/2007/09/03/prsb0903.htm
HSL11384
Jackson TJ.
Health technology assessment in Australia: challenges ahead
MJA 2007 Sep 3;187:(5):262-264
http://www.mja.com.au/public/issues/187_05_030907/jak10484_fm.html
HSL11385
Walley T.
Health technology assessment in England: assessment and appraisal
MJA 2007 Sep 3;187:(5):283-285
http://www.mja.com.au/public/issues/187_05_030907/wal10714_fm.html
HSL11386
Hailey DM
Health technology assessment in Canada: diversity and evolution
MJA 2007 Sep 3;187:(5):286-288
http://www.mja.com.au/public/issues/187_05_030907/hai10766_fm.html
HSL11387
Petherick ES, Villanueva EV, Dumville J, Bryan EJ, Dharmage S.
An evaluation of methods used in health technology assessments produced for the Medical Services Advisory Committee
MJA 2007 Sep 3;187:(5):289-292
http://www.mja.com.au/public/issues/187_05_030907/pet10017_fm.html
HSL11388
Halasz G.
Medical professionalism: it is really under threat?
MJA 2007 Sep 3;187:(5):318
http://www.mja.com.au/public/issues/187_05_030907/letters_030907_fm-5.html
HSL11389
Glasziou PP.
Publishing and reporting clinical trials
Med J Aust 2007 Sep 3;187:(5):282
http://www.mja.com.au/public/bookroom/2007/glasziou/glasziou.html
HSL11393
Mansfield P.
Xenical, the drug that dare not speak its name
Crikey 2007 Sep 3
http://www.crikey.com.au/Politics/20070903-Regulatory-spat-over-pill-for-the-fat.html
HSL11405
Bartz D.
Tech, drug companies battle over patent reform
Reuters 2007 Sep 3
http://biz.yahoo.com/rb/070903/patents_congress.html?.v=2
HSL11751
Marchetti S, Schellens JH.
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials.
Br J Cancer 2007 Sep 3;97:(5):577-81
http://www.nature.com/bjc/journal/v97/n5/abs/6603925a.html
HSL11899
Vladeck DC.
The Difficult Case of Direct-to-Consumer Drug Advertising
41 Loyola Los Angeles Law Review (forthcoming 2008) 2007 Sep 3;
http://lsr.nellco.org/cgi/viewcontent.cgi?article=1002&context=georgetown/ois
HSL12154
Kucinich D.
Get rid of the for-profits: Healthcare can no longer be a commodity for sale to those who can afford it
Mod Healthc 2007 Sep 3;37:(35):40
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17957898
HSL11397
Policing pharma
Financial Times 2007 Sep 2
http://www.ft.com/cms/s/5c8fdc2a-5985-11dc-aef5-0000779fd2ac,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F5c8fdc2a-5985-11dc-aef5-0000779fd2ac.html&_i_referer=http%3A%2F%2Fwww.google.com.au%2Fsearch%3Fsourceid%3Dnavclient
HSL11350
Butcher J.
The story of fenoterol
The Lancet 2007 Sep 1;370:(9589):732
http://www.thelancet.com/journals/lancet/article/PIIS0140673607613610/fulltext
HSL11351
Smith R.
Should we loosen the grip on drug companies?
BMJ 2007 Sep 1;335:(7617):454
http://www.bmj.com/cgi/content/short/335/7617/454?etoc
HSL11318
Jones SC, Lynch M.
Non-advertising alcohol promotions in licensed premises: does the Code of Practice ensure responsible promotion of alcohol?
Drug Alcohol Rev 2007 Sep;26:(5):477-85
http://www.informaworld.com/smpp/content?content=10.1080/09595230701494390
HSL11396
Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Arch Gen Psychiatry 2007 Sep;64:(9):1032-1039
http://archpsyc.ama-assn.org/cgi/content/short/64/9/1032
HSL11407
Cassels A.
Lock up your daughters Gardasil is on the loose
Common Ground 2007 Sep
http://commonground.ca/iss/0709194/cg194_cassels.shtml
HSL11414
An S.
Attitude Toward Direct-to-Consumer Advertising and Drug Inquiry Intention: The Moderating Role of Perceived Knowledge.
J Health Commun 2007 Sep;12:(6):567-80
http://www.informaworld.com/smpp/content?content=10.1080/10810730701508633
HSL11435
Kallen A, Woloshin S, Shu J, Juhl E, Schwartz L.
Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report.
Health Aff (Millwood) 2007 Sep-Oct;26:(5):1392-8
http://content.healthaffairs.org/cgi/content/abstract/26/5/1392
HSL11477
Vitry A, Mintzes B, Lexchin J
Direct-to-consumer advertising policy in Australia: realism in whose interests?
Internal Medicine Journal 2007 Sep;37:(9):665–666
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01447.x
HSL11478
Jordens CFC, Kerridge IH, Ankeny RA, MacKenzie FJ, McPhee J.
Reply
Internal Medicine Journal 2007 Sep;37:(9):666-667
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01448.x
HSL11519
Seston EM, Ashcroft DM, Griffiths CE.
Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.
Arch Dermatol 2007 Sep;143:(9):1175-9
http://archderm.ama-assn.org/cgi/content/full/143/9/1175
HSL11557
Ozdemir C, Akdis CA.
Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
Expert Opin Investig Drugs 2007 Sep;16:(9):1327-44
http://www.expertopin.com/doi/abs/10.1517/13543784.16.9.1327
HSL11558
Feuerstein GZ, Ruffolo RR.
Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective.
Expert Opin Investig Drugs 2007 Sep;16:(9):1315-26
http://www.expertopin.com/doi/abs/10.1517/13543784.16.9.1315
HSL11564
O'Mara P.
Is Breastfeeding in Trouble?
Mothering Magazine 2007 Sep-Oct
http://www.mothering.com/guest_editors/quiet_place/quiet_place.html
HSL11588
Pena C, Bowsher K, Costello A, De Luca R, Doll S, Li K, Schroeder M, Stevens T.
An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
IEEE Trans Neural Syst Rehabil Eng 2007 Sep;15:(3):421-4
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17894274
HSL11669
[No authors listed].
Take nutrition claims with a grain of salt. Dietary studies sponsored by the food industry are often biased
Sci Am. 2007 Sep;297:(3):38, 40
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17784619
HSL11687
Ross CJ, Carleton B, Warn DG, Stenton SB, Rassekh SR, Hayden MR.
Genotypic Approaches to Therapy in Children: A National Active Surveillance Network (GATC) to Study the Pharmacogenomics of Severe Adverse Drug Reactions in Children.
Ann N Y Acad Sci 2007 Sep;1110:177-92
http://www.annalsnyas.org/cgi/content/abstract/1110/1/177
HSL11688
Korczyn AD.
Drug trials in dementia: challenging ethical dilemmas.
Curr Alzheimer Res 2007 Sep;4:(4):468-72
http://www.ingentaconnect.com/content/ben/car/2007/00000004/00000004/art00018?token=00511708ec5aa35264f65263a3d4f58762f467c405847447b23446c244044765720745d3e3ffaeb23
HSL11726
Castano Riera EJ, Oterino de la Fuente D, Rodriguez Rodrigueza RM.
[The advertising message of drugs advertisements in Spanish medical journals.]
Gac Sanit 2007 Sep-Oct;21:(5):371-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17916300
HSL11738
Canadian Health Services Research Foundation.
Myth: Direct-to-consumer advertising is educational for patients
Myth Busters: A series of essays giving the research evidence behind Canadian health care debates 2007 Sep
http://www.chsrf.ca/mythbusters/pdf/myth27_e.pdf
HSL11749
Weaver DJ, Sorrells-Jones J.
The business case as a strategic tool for change.
J Nurs Adm 2007 Sep;37:(9):414-9
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005110-200709000-00008
HSL11750
Taylor-Zapata P, Mattison DR.
Making progress for how medicines are used in children.
Arch Pediatr Adolesc Med 2007 Sep;161:(9):916
http://archpedi.ama-assn.org/cgi/content/full/161/9/916
HSL11796
Oversteegen L, Rovini H, Belsey MJ.
Respiratory drug market dynamics.
Nat Rev Drug Discov 2007 Sep;6:(9):695-6
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17907343
HSL11816
Mackie P, Sim F.
A question of rhetoric.
Public Health 2007 Sep;121:(9):641-2
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B73H6-4P59RYM-1&_user=10&_coverDate=09%2F30%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=ead9429b6c0009b972ee01b7c5f15a17
HSL19371
Bras PL, Ricordeau P, Roussille B, Saintoyant V
L'information des médecins généralistes sur le médicament
Inspection générale des affaires sociales 2007 Sep
http://lesrapports.ladocumentationfrancaise.fr/BRP/074000703/0000.pdf
HSL11884
Bischoff A.
Sounding the Pharma Alarm: Four accounts of the rise of the pharmaceutical industry
Greenspiration 2007 Sep
http://www.greenspiration.org/drug/articles/briarpatch.htm
HSL11913
Cohen-Kohler JC, Esmail LC.
Scientific misconduct, the pharmaceutical industry, and the tragedy of institutions.
Med Law 2007 Sep;26:(3):431-46
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17970244
HSL11920
Health Council of Canada
Safe and Sound: Optimizing Prescribing Behaviours — Summary of Main Themes and Insights (Report on a Policy Symposium).
Toronto: Health Council of Canada 2007 Sep
http://www.healthcouncilcanada.ca/docs/rpts/2007/pharma/HCC_Symp_Sum_EN_FINAL%20web.pdf
HSL11938
Schachter AD, Ramoni MF, Baio G, Roberts TG Jr, Finkelstein SN.
Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities.
Value Health 2007 Sep-Oct;10:(5):377-85
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4733.2007.00191.x
HSL11942
Capozzi JD.
Physician advertising: evaluation of a sample advertisement.
J Bone Joint Surg Am 2007 Sep;89:(9):2089-91
http://www.ejbjs.org/cgi/content/full/89/9/2089
HSL11945
Mrayyan MT, Shishani K, Al-Faouri I.
Rate, causes and reporting of medication errors in Jordan: nurses' perspectives.
J Nurs Manag 2007 Sep;15:(6):659-70
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2834.2007.00724.x
HSL11978
Lamarque V, Pletan Y.
[The Pharmaceutical Industry and the adverse effects of the drugs].
Ann Pharm Fr 2007 Sep;65:(5):308-14
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=260&CodeRevue4=APF&Path=REVUE/APF/2007/65/5/ARTICLE11942567985.xml&Locations=
HSL11979
Imbs JL, Welsch M.
[Clinical assessment of drug safety].
Ann Pharm Fr 2007 Sep;65:(5):298-302
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=260&CodeRevue4=APF&Path=REVUE/APF/2007/65/5/ARTICLE11942567983.xml&Locations=
HSL12006
Sikora K.
Cost to the NHS of Roche oncology treatments.
J R Soc Med 2007 Sep;100:(9):396-7
http://www.jrsm.org/cgi/content/full/100/9/396-b
HSL12007
Miller GM, Stripp R.
A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown.
Leg Med (Tokyo) 2007 Sep;9:(5):258-64
http://linkinghub.elsevier.com/retrieve/pii/S1344-6223(07)00057-0
HSL12150
Wilgenbus K, Hill R, Warrander A, Kakkar S, Steiness E, Wessel R.
What pharma wants.
Nat Biotechnol 2007 Sep;25:(9):967-9
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17977088
HSL12152
Lexchin J.
The secret things belong unto the Lord our God: secrecy in the pharmaceutical arena.
Med Law 2007 Sep;26:(3):417-30
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17970243
HSL12161
Brownback S.
Eliminating neglected diseases: impact of published paper.
Health Aff (Millwood) 2007 Sep-Oct;26:(5):1509
http://content.healthaffairs.org/cgi/content/full/26/5/1509
HSL12164
Lowe JA 3rd, Jones P.
Biopharmaceuticals and the future of the pharmaceutical industry.
Curr Opin Drug Discov Devel 2007 Sep;10:(5):513-4
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17786848
HSL12165
Landau WM.
Pertinacious prescription of practice paradigms: the ethical burden of coercive clinical guidelines.
Curr Neurol Neurosci Rep 2007 Sep;7:(5):355-8
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17764623
HSL12166
Cohen H.
Protecting patients from harm: reduce the risks of high-alert drugs.
Nursing 2007 Sep;37:(9):49-55
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00152193-200709000-00040
HSL12199
Fowler C.
Contentious issue of funding and the pharmaceutical industry--should service user groups take the big pharma shilling, and and what are the costs if they do?
Ment Health Today 2007 Sep;:40:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17933061
HSL12200
Chen JT, Summers KH.
Pharmaceutical manufacturer prescription assistance programs: are they worth it?
J Manag Care Pharm 2007 Sep;13:(7):611-3
http://www.amcp.org/data/jmcp/JMCPMaga_Sept%2007_611-613.pdf
HSL12202
Wick C, Egger M, Trelle S, Jüni P, Fey MF.
The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry.
Ann Oncol 2007 Sep;18:(9):1580-2
http://annonc.oxfordjournals.org/cgi/content/full/18/9/1580
HSL12203
Coleman MP.
Not credible: a subversion of science by the pharmaceutical industry: Commentary on a global comparison regarding patient access to cancer drugs
Ann Oncol 2007 Sep;18:(Suppl 3):175
http://annonc.oxfordjournals.org/cgi/content/full/18/9/1433
HSL12206
Volkers AC, Heerdink ER, van Dijk L.
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Pharmacoepidemiol Drug Saf 2007 Sep;16:(9):1054-62
http://www3.interscience.wiley.com/cgi-bin/abstract/114277040/ABSTRACT?CRETRY=1&SRETRY=0
HSL12207
Dean AJ, Hendy A, McGuire T.
Antidepressants in children and adolescents--changes in utilisation after safety warnings.
Pharmacoepidemiol Drug Saf 2007 Sep;16:(9):1048-53
http://www3.interscience.wiley.com/cgi-bin/abstract/114210439/ABSTRACT
HSL12253
Klotz U.
The bridging function of clinical pharmacology.
Eur J Clin Pharmacol 2007 Sep;63:(9):817-9
http://www.springerlink.com/content/y0h8406051668611/
HSL12377
Kale SA, Barkin RL.
Tactics of the physician-controlled counter--detail and the imminent risk of not changing pharma's detail relationship with physicians.
J Opioid Manag 2007 Sep-Oct;3:(5):239-41
http://www.ncbi.nlm.nih.gov/pubmed/18181376
HSL12388
Goldsmith D, Kuhlmann M, Covic A.
Through the looking glass: the protein science of biosimilars.
Clin Exp Nephrol 2007 Sep;11:(3):191-5
http://www.ncbi.nlm.nih.gov/pubmed/17891344
HSL12403
Holleman F, Gale EA.
Nice insulins, pity about the evidence.
Diabetologia 2007 Sep;50:(9):1783-90
http://www.springerlink.com/content/qt85387u68h1x487/
HSL12404
Halban PA.
The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
Diabetologia 2007 Sep;50:(9):1791-4
http://www.springerlink.com/content/e247801475621302/
HSL12449
Schwartz LM, Woloshin S, Welch HG.
The drug facts box: providing consumers with simple tabular data on drug benefit and harm.
Med Decis Making 2007 Sep-Oct;27:(5):655-62
http://mdm.sagepub.com/cgi/reprint/27/5/655
HSL12499
Solomon LM, Sieczkiewicz GJ.
Impact of the US Patent System on the promise of personalized medicine.
Gend Med 2007 Sep;4:(3):187-92
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7MDM-4R5PGRY-2&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=b3eee273e27774ae1c9836eb5c394027
HSL12586
Massol J, Puech A, Boissel JP.
How to anticipate the assessment of the public health benefit of new medicines?
Therapie 2007 Sep-Oct;62:(5):427-35
http://www.journal-therapie.org/index.php?option=article&access=doi&doi=10.2515/therapie:2007071
HSL12603
Brieger WR, Salami KK, Oshiname FO.
Perceptions of drug color among drug sellers and consumers in rural southwestern Nigeria.
Res Social Adm Pharm 2007 Sep;3:(3):303-19
http://www.ncbi.nlm.nih.gov/pubmed/17945160
HSL12666
Wolf MS, Bailey SC.
Improving prescription drug labeling.
N C Med J 2007 Sep-Oct;68:(5):340-2
http://www.ncbi.nlm.nih.gov/pubmed/18183755?dopt=Abstract
HSL12679
MartÃn-Aranda P, Vázquez I, RodrÃguez de CossÃo A.
[Interns and the pharmaceutical industry].
Aten Primaria. 2007 Sep;39:(9):510-1
http://www.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.fulltext?pident=13109506
Page 74 of 206 pages ‹ First < 72 73 74 75 76 > Last ›
